Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.

Donato Rigante; C Gaggiano; J Sota; A Insalaco; R Cimaz; M Alessio; M Cattalini; R Gallizzi; MC Maggio; G Lopalco; Torre F La; C Fabiani; M Pardeo; AN Olivieri; P Sfriso; C Salvarani; S Grosso; C Bracaglia; Benedetti F De; L Cantarini

Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.

Donato Rigante, C Gaggiano, J Sota, A Insalaco, R Cimaz, M Alessio, M Cattalini, R Gallizzi, MC Maggio, G Lopalco, Torre F La, C Fabiani, M Pardeo, AN Olivieri, P Sfriso, C Salvarani, S Grosso, C Bracaglia, Benedetti F De, L Cantarini

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

We have evaluated drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. Our findings suggest an excellent overall drug retention rate for both anakinra and canakinumab that might be further augmented by paying attention to adverse events and employing these agents as first-line biologics in an early disease phase.

Lingua originale	English
pagine (da-a)	1-2
Numero di pagine	2
Rivista	PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume	10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Stato di pubblicazione	Pubblicato - 2019

Keywords

Juvenile idiopathic arthritis

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.'. Insieme formano una fingerprint unica.

Cita questo

Rigante, D., Gaggiano, C., Sota, J., Insalaco, A., Cimaz, R., Alessio, M., Cattalini, M., Gallizzi, R., Maggio, MC., Lopalco, G., La, T. F., Fabiani, C., Pardeo, M., Olivieri, AN., Sfriso, P., Salvarani, C., Grosso, S., Bracaglia, C., De, B. F., & Cantarini, L. (2019). Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID), 1-2.

Rigante, Donato ; Gaggiano, C ; Sota, J ; Insalaco, A ; Cimaz, R ; Alessio, M ; Cattalini, M ; Gallizzi, R ; Maggio, MC ; Lopalco, G ; La, Torre F ; Fabiani, C ; Pardeo, M ; Olivieri, AN ; Sfriso, P ; Salvarani, C ; Grosso, S ; Bracaglia, C ; De, Benedetti F ; Cantarini, L. / Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. In: PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL. 2019 ; Vol. 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID). pagg. 1-2.

@article{046d3fafbf454a4a9327bb105dbe9a02,

title = "Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.",

abstract = "We have evaluated drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. Our findings suggest an excellent overall drug retention rate for both anakinra and canakinumab that might be further augmented by paying attention to adverse events and employing these agents as first-line biologics in an early disease phase.",

keywords = "Juvenile idiopathic arthritis, Juvenile idiopathic arthritis",

author = "Donato Rigante and C Gaggiano and J Sota and A Insalaco and R Cimaz and M Alessio and M Cattalini and R Gallizzi and MC Maggio and G Lopalco and La, {Torre F} and C Fabiani and M Pardeo and AN Olivieri and P Sfriso and C Salvarani and S Grosso and C Bracaglia and De, {Benedetti F} and L Cantarini",

year = "2019",

language = "English",

volume = "10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)",

pages = "1--2",

journal = "Pediatric Rheumatology",

issn = "1546-0096",

publisher = "[Chicago. Ill. : University of Chicago, 2003]-",

}

Rigante, D, Gaggiano, C, Sota, J, Insalaco, A, Cimaz, R, Alessio, M, Cattalini, M, Gallizzi, R, Maggio, MC, Lopalco, G, La, TF, Fabiani, C, Pardeo, M, Olivieri, AN, Sfriso, P, Salvarani, C, Grosso, S, Bracaglia, C, De, BF & Cantarini, L 2019, 'Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.', PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, vol. 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID), pagg. 1-2.

Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. / Rigante, Donato; Gaggiano, C; Sota, J; Insalaco, A; Cimaz, R; Alessio, M; Cattalini, M; Gallizzi, R; Maggio, MC; Lopalco, G; La, Torre F; Fabiani, C; Pardeo, M; Olivieri, AN; Sfriso, P; Salvarani, C; Grosso, S; Bracaglia, C; De, Benedetti F; Cantarini, L.

In: PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, Vol. 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID), 2019, pag. 1-2.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.

AU - Rigante, Donato

AU - Gaggiano, C

AU - Sota, J

AU - Insalaco, A

AU - Cimaz, R

AU - Alessio, M

AU - Cattalini, M

AU - Gallizzi, R

AU - Maggio, MC

AU - Lopalco, G

AU - La, Torre F

AU - Fabiani, C

AU - Pardeo, M

AU - Olivieri, AN

AU - Sfriso, P

AU - Salvarani, C

AU - Grosso, S

AU - Bracaglia, C

AU - De, Benedetti F

AU - Cantarini, L

PY - 2019

Y1 - 2019

N2 - We have evaluated drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. Our findings suggest an excellent overall drug retention rate for both anakinra and canakinumab that might be further augmented by paying attention to adverse events and employing these agents as first-line biologics in an early disease phase.

AB - We have evaluated drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. Our findings suggest an excellent overall drug retention rate for both anakinra and canakinumab that might be further augmented by paying attention to adverse events and employing these agents as first-line biologics in an early disease phase.

KW - Juvenile idiopathic arthritis

UR - http://hdl.handle.net/10807/136251

M3 - Article

VL - 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)

SP - 1

EP - 2

JO - Pediatric Rheumatology

JF - Pediatric Rheumatology

SN - 1546-0096

ER -